PVT1 and colorectal carcinoma: However, the genotype and allele frequencies during the evaluation of PVT1 rs13255292 in CRC vs. non-CRC groups showed only a significant difference in the dominant model (CT + TT vs. CC) as a protective predictor adjusted OR = 0.59, p = 0.034 (Table 2 and Table 3).